Vaccines produced by conventional means to control major infectious diseases of man and animals
- PMID: 2648772
- PMCID: PMC7150235
- DOI: 10.1016/b978-0-12-039233-9.50005-6
Vaccines produced by conventional means to control major infectious diseases of man and animals
Abstract
This chapter reviews the development of some of vaccines and their use in controlling such major diseases as diphtheria, rinderpest, Newcastle disease, smallpox, pertussis, yellow fever, rabies, etc. Park–Williams Number 8 (PW8) strain is used to make diphtherial toxoid for vaccines. As a source of toxin, it is rendered nontoxic by incubation with formalin under alkaline conditions. The product's retention of antigenicity, enabling it to induce antitoxin antibodies, makes it an excellent pediatric vaccine. Vaccine against Rinderpest Virus was developed by Koch in 1897 by administering bile from infected cattle. Animals that survived were permanently immune. Formalin- and chloroform-inactivated vaccines were developed using tissues from the infected animals. For the control of Newcastle disease, a number of attenuated live-virus vaccines have been developed which are widely used to control the disease. The Bl strain, the LaSota strain, and the F strain are used to immunize birds of all ages by different routes, including by addition to drinking water and by spraying. Protection against rabies correlates with SN antibody, which can be assessed by a number of tests. Pasteur's classical vaccine, developed from infected spinal cord tissue dried at room temperature for 3–14 days, was given in a series of 21–28 inoculations beginning with material dried the longest and progressing through material dried for only 3 days.
Similar articles
-
The development of biosynthetic vaccines.Adv Vet Sci Comp Med. 1989;33:109-72. doi: 10.1016/b978-0-12-039233-9.50008-1. Adv Vet Sci Comp Med. 1989. PMID: 2648773 Review. No abstract available.
-
Combination vaccines.Adv Pharmacol. 1997;39:393-423. doi: 10.1016/s1054-3589(08)60077-0. Adv Pharmacol. 1997. PMID: 9160121 Review. No abstract available.
-
[Prevention of infective diseases].Aten Primaria. 2012 Jun;44 Suppl 1(Suppl 1):36-51. doi: 10.1016/S0212-6567(12)70013-6. Aten Primaria. 2012. PMID: 23399506 Free PMC article. Spanish. No abstract available.
-
Invasive diseases: new vaccines and vaccination strategies.J Prev Med Hyg. 2012 Jun;53(2):49. J Prev Med Hyg. 2012. PMID: 23240159 No abstract available.
-
Therapeutic vaccines against infectious diseases.Curr Opin Microbiol. 2003 Oct;6(5):462-71. doi: 10.1016/j.mib.2003.08.002. Curr Opin Microbiol. 2003. PMID: 14572538 Review.
Cited by
-
Molecular and biochemical characterization of a protective 40-kilodalton antigen from Corynebacterium pseudotuberculosis.Infect Immun. 1995 Jan;63(1):206-11. doi: 10.1128/iai.63.1.206-211.1995. Infect Immun. 1995. PMID: 7806359 Free PMC article.
-
Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV.J Virol. 1990 Aug;64(8):3694-700. doi: 10.1128/JVI.64.8.3694-3700.1990. J Virol. 1990. PMID: 2164591 Free PMC article.
References
-
- Acharya I.L., Lowe C.U., Thapa R., Gurubacharya V.L. N. Engl. J. Med. 1987;317:1101–1104. - PubMed
-
- Alexander R.A., DuToit R.M. Onderstepoort J. Vet. Sci. Anim. Ind. 1934;2:357.
-
- Alexander R.A., Haig D.A., Adelaar T.F. Onderstepoort J. Vet. Sci. Anim. Ind. 1947;21:231–241. - PubMed
-
- Anderson M.J., Pattison J.R. Arch. Virol. 1984;82:137–148. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials